Literature DB >> 7788916

How do we explain the clinical benefits of estrogen? From bedside to bench.

M Gerhard, P Ganz.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7788916     DOI： 10.1161/01.cir.92.1.5

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  30 in total

Review 1.  Hormone replacement therapy and cardiovascular risk.

Authors:  M Gerhard-Herman; N Hamburg; P Ganz
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

2.  Food patterns and nutritional assessment in Galician university students.

Authors:  José J Porto-Arias; Tania Lorenzo; Alexandre Lamas; Patricia Regal; Alejandra Cardelle-Cobas; Alberto Cepeda
Journal:  J Physiol Biochem       Date:  2017-08-04       Impact factor: 4.158

3.  Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals.

Authors:  K T Khaw
Journal:  BMJ       Date:  1998-06-20

Review 4.  Hormone replacement therapy in young women with surgical primary ovarian insufficiency.

Authors:  Philip M Sarrel; Shannon D Sullivan; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-10-25       Impact factor: 7.329

5.  Addition of Estradiol to Cross-Sex Testosterone Therapy Reduces Atherosclerosis Plaque Formation in Female ApoE-/- Mice.

Authors:  Laura G Goetz; Ramanaiah Mamillapalli; Cagdas Sahin; Masoumeh Majidi-Zolbin; Guanghao Ge; Arya Mani; Hugh S Taylor
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

6.  Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells.

Authors:  R Abu-Ghazaleh; J Kabir; H Jia; M Lobo; I Zachary
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

7.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.

Authors:  Ossama M Reslan; Zongzhi Yin; Graciliano R A do Nascimento; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

9.  Risk factors for age-related maculopathy.

Authors:  Paul P Connell; Pearse A Keane; Evelyn C O'Neill; Rasha W Altaie; Edward Loane; Kumari Neelam; John M Nolan; Stephen Beatty
Journal:  J Ophthalmol       Date:  2009-09-06       Impact factor: 1.909

10.  The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years.

Authors:  Philip M Sarrel; Valentine Y Njike; Valentina Vinante; David L Katz
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.